Cargando...

New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors

Over the past several years many advances have been made in our understanding of critical pathways involved in carcinogenesis and tumor growth. These advances have led to the investigation of small molecule inhibitors of the ErbB family of receptor tyrosine kinases across a broad spectrum of maligna...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lin, Nancy U, Winer, Eric P
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2004
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC549180/
https://ncbi.nlm.nih.gov/pubmed/15318926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr919
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!